Case and Research Letter
Can We Improve Prognosis in Hidradenitis Suppurativa? Identifying Patients in the Window of Opportunity
¿Podemos mejorar el pronóstico de la hidradenitis supurativa? Definiendo a los pacientes en la «ventana de oportunidad»
Read
2566
Timeswas read the article
842
Total PDF
1724
Total HTML
Share statistics
array:24 [ "pii" => "S0001731023009535" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.11.012" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "3762" "copyright" => "AEDV" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:T213-T214" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0001731023005227" "issn" => "00017310" "doi" => "10.1016/j.ad.2023.05.025" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "3568" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:215-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Uso de nadolol en el tratamiento de hemangiomas infantiles previamente tratados con propranolol" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "215" "paginaFinal" => "217" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Nadolol for Infantile Hemangiomas Previously Treated with Propranolol" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2110 "Ancho" => 1740 "Tamanyo" => 308075 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Ejemplos de respuesta al tratamiento con nadolol: A) Hemangioma focal profundo en el párpado inferior izquierdo, edad inicio nadolol: 24 meses, edad fin nadolol: 43 meses. Buena respuesta. B) Hemangioma dorsal focal profundo, edad inicio nadolol: 40 meses, edad fin nadolol: 48 meses. Buena respuesta. C) Hemangioma focal superficial labio inferior, edad inicio nadolol: 11 meses, edad fin nadolol: 27 meses. Buena respuesta. D) Hemangioma escapular focal mixto, edad inicio nadolol: 30 meses, edad fin nadolol: 45 meses. Respuesta parcial.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Colmenero Sendra, J. del Boz González, J.M. Segura Palacios, I. Valladares Millán, M. Eguiluz Solana, M. de Troya Martín" "autores" => array:6 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Colmenero Sendra" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "del Boz González" ] 2 => array:2 [ "nombre" => "J.M." "apellidos" => "Segura Palacios" ] 3 => array:2 [ "nombre" => "I." "apellidos" => "Valladares Millán" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Eguiluz Solana" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "de Troya Martín" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023005227?idApp=UINPBA000044" "url" => "/00017310/0000011500000002/v2_202402280504/S0001731023005227/v2_202402280504/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0001731023001795" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.12.005" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "3425" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:213-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "¿Podemos mejorar el pronóstico de la hidradenitis supurativa? Definiendo a los pacientes en la «ventana de oportunidad»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "213" "paginaFinal" => "214" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Can We Improve Prognosis in Hidradenitis Suppurativa? Identifying Patients in the Window of Opportunity" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1179 "Ancho" => 1675 "Tamanyo" => 131392 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Representación gráfica de la «ventana de oportunidad»/window of opportunity. Fuente: Martorell, et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a>.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Melgosa Ramos, R. García-Ruiz, A. Mateu Puchades, A. Martorell" "autores" => array:4 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Melgosa Ramos" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "García-Ruiz" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Mateu Puchades" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martorell" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023001795?idApp=UINPBA000044" "url" => "/00017310/0000011500000002/v2_202402280504/S0001731023001795/v2_202402280504/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0001731023001795" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.12.005" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "3425" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2024;115:213-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "¿Podemos mejorar el pronóstico de la hidradenitis supurativa? Definiendo a los pacientes en la «ventana de oportunidad»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "213" "paginaFinal" => "214" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Can We Improve Prognosis in Hidradenitis Suppurativa? Identifying Patients in the Window of Opportunity" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1179 "Ancho" => 1675 "Tamanyo" => 131392 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Representación gráfica de la «ventana de oportunidad»/window of opportunity. Fuente: Martorell, et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a>.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Melgosa Ramos, R. García-Ruiz, A. Mateu Puchades, A. Martorell" "autores" => array:4 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Melgosa Ramos" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "García-Ruiz" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Mateu Puchades" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martorell" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023001795?idApp=UINPBA000044" "url" => "/00017310/0000011500000002/v2_202402280504/S0001731023001795/v2_202402280504/es/main.assets" ] ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => " Can We Improve Prognosis in Hidradenitis Suppurativa? Identifying Patients in the Window of Opportunity" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor,</span>" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T213" "paginaFinal" => "T214" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "F.J. Melgosa Ramos, R. García-Ruiz, A. Mateu Puchades, A. Martorell" "autores" => array:4 [ 0 => array:4 [ "nombre" => "F.J." "apellidos" => "Melgosa Ramos" "email" => array:1 [ 0 => "javimelgo2017@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "R." "apellidos" => "García-Ruiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "A." "apellidos" => "Mateu Puchades" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "A." "apellidos" => "Martorell" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital de Manises, Valencia, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Podemos mejorar el pronóstico de la hidradenitis supurativa? Definiendo a los pacientes en la «ventana de oportunidad»" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1180 "Ancho" => 1676 "Tamanyo" => 143879 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Graphical representation of the “window of opportunity.” Source: Martorell et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a>.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hidradenitis suppurativa (HS) is a chronic immune-mediated inflammatory illness of the pilosebaceous-apocrine unit,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> that has a tremendous impact on the patients’ quality of life, deteriorating their health, and limiting their social relations.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2,3</span></a> In an effort to optimize the management of this condition, some authors have categorized patients with HS into location-based clinical phenotypes,<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> and predominant types of lesion (follicular, inflammatory, and mixed profiles).<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> They have also tried to categorize the lesions, especially tunnels, using imaging modalities. Despite of its high prevalence (nearly 1% in developed countries) HS still remains relatively unknown to numerous health professionals, leading to delayed diagnosis, incorrect therapeutic approaches, and disease progression. Some authors have suggested that this progression, along with the presence of certain risk factors often associated with patients with HS, such as smoking and obesity, could lead to a potentially proinflammatory systemic environment that triggers comorbidities and lowers life expectancy, in a similar way to what has already been hypothesized for patients with psoriasis, resulting in more health care spending.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> The approval of adalimumab to treat moderate-to-severe HS by regulatory agencies marked a paradigm shift in the management of patients with the inflammatory phenotype, which has proven to be an independent risk factor for disease progression.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> In recent years, there has been a deeper understanding of the disease pathogenesis, including molecular pathways and interleukins (IL) other than TNF-alpha (IL1, IL-6, IL-10, IL-12/23, IL-17, IL-22, complement, and janus kinase, among others)<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7,8</span></a> that has led to the development of new molecules and the search for possible new indications in existing drugs, thus giving hope to many patients. Unfortunately, currently, due to the type and severity of the lesions, many patients currently require a combination of medical and surgical treatment.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a> In many cases, advanced therapies are just a means to prepare the patient for potentially aggressive surgical interventions associated with a non-negligible rate of recurrence depending on the location and procedure performed. Additionally, there is significant heterogeneity in the use of scores/measurement systems in the routine clinical practice, further complicating the already complex standardized management.</p><p id="par0010" class="elsevierStylePara elsevierViewall">For all these reasons, it is of paramount importance to perform proper clinical assessments. Guided by non-invasive tools like the ultrasound,<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> these assessments should enable us to achieve early diagnoses of the disease and its phenotype, identify active and subclinical lesions, and patients in the so-called “window of opportunity” (that stage of the disease when medical treatment is most effective because we’re dealing with reversible lesions). This is consistent with that stage in which patients exhibit nodular/abscess-type lesions (<a class="elsevierStyleCrossRef" href="#fig0005">figure 1</a>).<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> In this group of patients, early and aggressive interventions with advanced therapies, along with a proper health educational strategy, could have a significant impact on prognosis. Overall, the patients who could be included in this category (<a class="elsevierStyleCrossRef" href="#tbl0005">table 1</a>) are those who present with the Martorell's inflammatory phenotype, characterized by abscess-like onsets in the absence of comedone-like lesions.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> Also, individuals with an increasingly growing number of inflammatory nodules despite conventional systemic treatment, patients with perianal abscesses, and those with a mixed form of Martorell's HS,<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> including patients with an initially follicular phenotype who start developing abscesses in > 2 anatomical areas, with a long history of smoking (< 10 cigarettes/day for > 10 years). This aggressive approach in the early stages of the disease could represent a paradigm shift in the management of this condition, thus preventing progression to mutilating forms of the disease, reducing cardiovascular risk, and improving the patients’ quality of life.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0015" class="elsevierStylePara elsevierViewall">None declared.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1180 "Ancho" => 1676 "Tamanyo" => 143879 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Graphical representation of the “window of opportunity.” Source: Martorell et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a>.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">These are the groups of patients potentially benefiting from early and aggressive treatment:<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A) Onset of HS with Martorell's inflammatory phenotype characterized by abscess-like onsets in the absence of comedone-like lesions. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">B) Individuals with an increasingly growing the number of inflammatory nodules despite conventional systemic treatment. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C) Patients with perianal abscesses. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">D) Individuals with a mixed form of Martorell's HS (patients with an initially follicular phenotype who start developing abscesses in <span class="elsevierStyleUnderline">></span> 2 anatomical regions) with a long history of smoking (<10 cigarettes/day for > 10 years). \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3470410.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">These groups of patients have been proposed by the authors based on the scientific medical evidence available to date.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Main groups of patient included in the so-called “window of opportunity.”.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.R. Goldburg" 1 => "B.E. Strober" 2 => "M.J. Payette" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2019.08.090" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol." "fecha" => "2020" "volumen" => "82" "paginaInicial" => "1045" "paginaFinal" => "1058" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31604104" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T.V. Nguyen" 1 => "G. Damiani" 2 => "L.A.V. Orenstein" 3 => "I. Hamzavi" 4 => "G.B. Jemec" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Eur Acad Dermatol Venereol." "fecha" => "2021" "volumen" => "35" "paginaInicial" => "50" "paginaFinal" => "61" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Montero-Vilchez" 1 => "P. Diaz-Calvillo" 2 => "J.A. Rodriguez-Pozo" 3 => "C. Cuenca-Barrales" 4 => "A. Martinez-Lopez" 5 => "S. Arias-Santiago" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijerph18136709" "Revista" => array:5 [ "tituloSerie" => "Int J Environ Res Public Health." "fecha" => "2021" "volumen" => "18" "paginaInicial" => "6709" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34206415" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Cazzaniga" 1 => "E. Pezzolo" 2 => "V. Bettoli" 3 => "D. Abeni" 4 => "A.V. Marzano" 5 => "A. Patrizi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jid.2020.08.032" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol." "fecha" => "2021" "volumen" => "141" "paginaInicial" => "1236" "paginaFinal" => "1242" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33098826" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Martorell" 1 => "A. Jfri" 2 => "S.B.L. Koster" 3 => "P. Gomez-Palencia" 4 => "M. Solera" 5 => "A. et al. Alfaro-Rubio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.16183" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol." "fecha" => "2020" "volumen" => "34" "paginaInicial" => "1309" "paginaFinal" => "1318" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31919904" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.J.M. Rodríguez-Zuñiga" 1 => "H.A. García-Perdomo" 2 => "A.G. Ortega-Loayza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr (Engl Ed)." "fecha" => "2019" "volumen" => "110" "paginaInicial" => "279" "paginaFinal" => "288" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hidradenitis suppurativa: Current and emerging treatments" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.R. Goldburg" 1 => "B.E. Strober" 2 => "M.J. Payette" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2019.08.089" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2020" "volumen" => "82" "paginaInicial" => "1061" "paginaFinal" => "1082" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31604100" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa/acne inversa-A narrative review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "U. Wollina" 1 => "P. Brzezinski" 2 => "A. Koch" 3 => "W.G. Philipp-Dormston" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dth.13877" "Revista" => array:5 [ "tituloSerie" => "Dermatol Ther." "fecha" => "2020" "volumen" => "33" "paginaInicial" => "e13877" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32558202" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Martorell" 1 => "F. Alfageme Roldán" 2 => "E. Vilarrasa Rull" 3 => "R. Ruiz-Villaverde" 4 => "J. Romaní De Gabriel" 5 => "F. García Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.15710" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol." "fecha" => "2019" "volumen" => "33" "paginaInicial" => "2137" "paginaFinal" => "2142" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31124183" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of patients with hidradenitis suppurativa" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Martorell" 1 => "A. Caballero" 2 => "Y. González Lama" 3 => "D. Jiménez-Gallo" 4 => "M. Lázaro Serrano" 5 => "J. Miranda" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0001-7310(17)30007-8" "Revista" => array:7 [ "tituloSerie" => "Actas Dermosifiliogr." "fecha" => "2016" "volumen" => "107" "numero" => "Suppl 2" "paginaInicial" => "32" "paginaFinal" => "42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28081768" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011500000002/v2_202402280504/S0001731023009535/v2_202402280504/en/main.assets" "Apartado" => array:4 [ "identificador" => "6160" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011500000002/v2_202402280504/S0001731023009535/v2_202402280504/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023009535?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 24 | 20 | 44 |
| 2024 October | 185 | 91 | 276 |
| 2024 September | 162 | 55 | 217 |
| 2024 August | 185 | 104 | 289 |
| 2024 July | 162 | 73 | 235 |
| 2024 June | 120 | 95 | 215 |
| 2024 May | 119 | 67 | 186 |
| 2024 April | 84 | 53 | 137 |
| 2024 March | 190 | 64 | 254 |
| 2024 February | 239 | 67 | 306 |
| 2024 January | 138 | 77 | 215 |
| 2023 December | 116 | 76 | 192 |
